港股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

麥科醫藥-B

28.420

+0.1000.35%

成交量：26.56萬

成交額：753.55萬

市值：94.28億

市盈率：- -

高：28.760

開：28.300

低：28.060

收：28.320

52周最高：45.040

52周最低：27.000

股本：3.32億

香港流通股本：2.80億

量比：0.64

換手率：0.09%

股息：- -

股息率：- -

淨資產收益率：--

總資產收益率：-33.17%

市淨率：-8.31

市盈率(LYR):- -

市銷率: 27596.63

資料載入中...

總覽公司新聞資訊公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞資訊

麥科醫藥-B(02335)存倉市值總計5.21億港元股東將1773.41萬股股票存入Merrill Lynch Far East

麥科醫藥-B(02335)獲納入恒生綜合指數成份股

麥科醫藥-B（02335）將於9月7日納入恒生綜合指數

陝西麥科醫藥科技（02335.HK）將於2026年9月7日納入恒生綜合指數

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/stock/02335"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02335","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02335\",,,,,undefined,":{"symbol":"02335","market":"HK","secType":"STK","nameCN":"麥科醫藥-B","latestPrice":28.42,"timestamp":1787645292941,"preClose":28.32,"halted":0,"volume":265600,"delay":0,"changeRate":0.003531073446327734,"floatShares":280071100,"shares":331740350,"eps":0,"marketStatus":"已收盤","change":0.1,"latestTime":"08-25 16:08:12","open":28.3,"high":28.76,"low":28.06,"amount":7535484,"amplitude":0.024718,"askPrice":28.42,"askSize":400,"bidPrice":28.16,"bidSize":600,"shortable":0,"etf":0,"ttmEps":-0.609,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1787707800000},"marketStatusCode":5,"adr":0,"listingDate":1782230400000,"exchange":"SEHK","adjPreClose":28.32,"openAndCloseTimeList":[[1787621400000,1787630400000],[1787634000000,1787644800000]],"volumeRatio":0.643723,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02335\",,,,,undefined,":{"symbol":"02335","floatShares":280071100,"roa":"-33.17%","roe":"--","lyrEps":0,"volumeRatio":0.643723,"shares":331740350,"dividePrice":0,"high":28.76,"amplitude":0.024718,"preClose":28.32,"low":28.06,"week52Low":27,"pbRate":"-8.31","psRate":"27596.63","week52High":45.04,"institutionHeld":0,"latestPrice":28.42,"committee":0.2,"eps":0,"divideRate":0,"volume":265600,"delay":0,"ttmEps":-0.609,"open":28.3,"prevYearClose":18.2,"prevWeekClose":29.36,"prevMonthClose":28.72,"prevQuarterClose":36.54,"fiveDayClose":31.74,"twentyDayClose":28.14,"sixtyDayClose":18.2},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02335\",params:#limit:5,,,undefined,":[{"date":"2026-08-28","symbol":"02335","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787880600000,"name":null,"time":"","dateTimestamp":1787846400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02335\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02335\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02335\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02335","date":"2026-08-24","current":-46.600985,"percent":0.952381,"low":-69.768231,"twenty":-62.850376,"median":-53.390071,"eighty":-45.876641,"high":-30.846573,"avg":-53.470019,"sd":8.908012,"marketCap":9394886712},"quantilePoints":[{"date":"2026-06-26","current":-62.263046,"twenty":-62.206329,"median":-60.152258,"eighty":-47.220229,"marketCap":13110378632},{"date":"2026-07-03","current":-59.036408,"twenty":-61.58898,"median":-58.586203,"eighty":-56.979685,"marketCap":12440263125},{"date":"2026-07-10","current":-67.90436,"twenty":-64.475349,"median":-60.719674,"eighty":-57.773147,"marketCap":14291374278},{"date":"2026-07-17","current":-63.579874,"twenty":-66.545041,"median":-62.752488,"eighty":-58.496163,"marketCap":13428849368},{"date":"2026-07-24","current":-53.390071,"twenty":-65.175311,"median":-60.719674,"eighty":-54.684103,"marketCap":11279171900},{"date":"2026-07-31","current":-45.013396,"twenty":-64.653423,"median":-59.036408,"eighty":-53.47914,"marketCap":9527582852},{"date":"2026-08-07","current":-44.926163,"twenty":-63.868877,"median":-57.071612,"eighty":-46.373695,"marketCap":9527582852},{"date":"2026-08-14","current":-46.337925,"twenty":-63.512285,"median":-53.986784,"eighty":-46.072055,"marketCap":9839418781},{"date":"2026-08-21","current":-45.768087,"twenty":-63.046152,"median":-53.612744,"eighty":-46.072055,"marketCap":9739896676},{"date":"2026-08-24","current":-44.162772,"twenty":-62.850376,"median":-53.390071,"eighty":-45.876641,"marketCap":9394886712}],"updateTime":1787644180742},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02335\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662320734","title":"麥科醫藥-B(02335)存倉市值總計5.21億港元 股東將1773.41萬股股票存入Merrill Lynch Far East","url":"https://stock-news.laohu8.com/highlight/detail?id=2662320734","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662320734?lang=zh_tw&edition=fundamental","pubTime":"2026-08-25 09:07","pubTimestamp":1787620021,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，8月24日，麦科医药-B(02335)出现存仓异动，存仓市值总计5.21亿港元，占比6.33%。该公司股东将1773.41万股股票存入Merrill Lynch Far East。\r\n\r\n　　麦科医药发布公告，根据恒生指数有限公司于2026年8月21日公布的截至2026年6月30日止期间的恒生指数系列季度检讨结果，公司已获选并将纳入为恒生综合指数(恒生综指)成份股，自2026年9月7日起生效。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260825/32345698.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1161","02335"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661240441","title":"麥科醫藥-B(02335)獲納入恒生綜合指數成份股","url":"https://stock-news.laohu8.com/highlight/detail?id=2661240441","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661240441?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 12:11","pubTimestamp":1787544686,"startTime":"0","endTime":"0","summary":"智通财经APP讯，麦科医药-B(02335)发布公告，根据恒生指数有限公司于2026年8月21日公布的截至2026年6月30日止期间的恒生指数系列季度检讨结果，本公司已获选并将纳入为恒生综合指数(恒生综指)成份股，自2026年9月7日起生效。于获纳入恒生综指成份股后，本公司H股预期将符合资格获纳入沪港通及深港通。沪港通及深港通是香港与中国内地资本市场投资者进行股票交易及投资的渠道。董事会相信，获纳入恒生综指反映资本市场对本公司价值及成长潜力的认可，这将有助于拓宽本公司股东基础及提升其H股的交易流动性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1484048.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02335","BK1161","HSCI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105527001","title":"麥科醫藥-B（02335）將於9月7日納入恒生綜合指數","url":"https://stock-news.laohu8.com/highlight/detail?id=1105527001","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105527001?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 12:05","pubTimestamp":1787544330,"startTime":"0","endTime":"0","summary":"麦科医药-B（02335）8月24日公告称，根据恒生指数有限公司在2026年8月21日公布的截至2026年6月30日止期间恒生指数系列季度检讨结果，公司H股将被纳入恒生综合指数，生效日期为2026年9月7日。\n公司表示，纳入恒生综合指数后，其H股预计将符合资格被纳入沪港通及深港通，为香港与内地资本市场投资者提供交易渠道。\n董事会认为，此次纳指显示资本市场对公司价值及成长潜力的认可，并有助于拓宽股东基础及提升H股交易流动性。\n公司提醒股东及潜在投资者在买卖公司股份时保持审慎。公告由公司主席、首席执行官兼执行董事王冰于2026年8月24日签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"a3893e2538b44a4c9453f52433cb6ed2","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02335"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140356227","title":"陝西麥科醫藥科技（02335.HK）將於2026年9月7日納入恒生綜合指數","url":"https://stock-news.laohu8.com/highlight/detail?id=1140356227","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1140356227?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 12:05","pubTimestamp":1787544313,"startTime":"0","endTime":"0","summary":"陕西麦科医药科技股份有限公司传来重磅消息——该公司将被正式纳入恒生综合指数，这一变动自2026年9月7日起生效。此次将陕西麦科医药科技纳入其中，无疑是对该公司市值、流动性及行业代表性等多方面指标的肯定。总而言之，陕西麦科医药科技即将跻身恒生综合指数成分股行列，这不仅是对其过往经营成果的认可，更预示着其在资本市场新征程上的启航。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02335"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":17,"pageCount":1,"totalSize":67,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/02335\",params:#limit:6,delay:false,,,undefined,":[]}}